The DEI Dilemma: Separate teams or embedded methods?

The DEI Dilemma: Separate teams or embedded methods? 
Clinical Leader; by Denise N. Bronner, PhD; 8/28/24 
In recent years, diversity, equity, and inclusion (DEI) has become a focal point in many industries, with the pharma sector being no exception. As political forces shift the societal climate to be increasingly DEI-averse, pharma sponsors face critical decisions regarding the implementation of DEI initiatives: Should DEI efforts be managed by a separate, dedicated DEI team or woven into the fabric of existing processes and departments? To answer that question, we must examine the advantages and drawbacks of both strategies, focusing on key factors like resource allocation, implementation efficiency, cultural integration, and the long-term impact on trial inclusivity. ... Integrating DEI into all aspects of a business is a complex task that requires careful planning and coordination. Without a clear strategy, efforts can become fragmented and ineffective.
Editor's Note: While this DEI discussion is written to the pharma industry, its DEI structures, strategies and outcomes apply to hospice and palliative care services.